Myocardial reperfusion is a pivotal component of cardiovascular care, encompassing the reinstatement of blood flow to the heart muscle following a period of ischemia. Ischemia arises when the blood supply to the heart is temporarily diminished or obstructed, often in the context of a myocardial infarction (heart attack). The primary goal of reperfusion is to alleviate ischemic conditions and mitigate damage to the cardiac tissue. Nonetheless, the restoration of blood flow during reperfusion is a double-edged sword. The abrupt reintroduction of oxygen to the ischemic tissue can trigger oxidative stress and inflammation, contributing to additional injury. Striking a balance between the benefits of reperfusion and the potential harm it may cause is a central challenge in managing cardiovascular diseases.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Cardiovascular mortality in colon cancer a patient characteristics analysis: Population-based study
Nouf, KAU, Saudi Arabia
Title : Improving Screening and Treatment of Iron Deficiency in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Cycle Quality Improvement Project
Danish Malik, University Hospitals Dorset NHS Foundation Trust, United Kingdom